Rubicon Analysis’s IPO opens on October 9, 2025, aiming to boost Rs 1,378 crore. With 98 per cent of its income from the US and powerful margin self-discipline, the pharma firm affords each promise and dangers. Must you subscribe?
Rubicon Analysis IPO: The nice and the unhealthy
Leave a comment
